Cargando…

Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study

OBJECTIVE: This study analysed utilisation of statins for new statin users and assessed market dynamics of statins in South Korea. DESIGN: This study is a retrospective cohort study. SETTING: The yearly claims data for statins were retrieved from the National Health Insurance Service-National Sample...

Descripción completa

Detalles Bibliográficos
Autores principales: Son, Kyung-Bok, Bae, SeungJin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430099/
https://www.ncbi.nlm.nih.gov/pubmed/30842117
http://dx.doi.org/10.1136/bmjopen-2018-026603
_version_ 1783405729048166400
author Son, Kyung-Bok
Bae, SeungJin
author_facet Son, Kyung-Bok
Bae, SeungJin
author_sort Son, Kyung-Bok
collection PubMed
description OBJECTIVE: This study analysed utilisation of statins for new statin users and assessed market dynamics of statins in South Korea. DESIGN: This study is a retrospective cohort study. SETTING: The yearly claims data for statins were retrieved from the National Health Insurance Service-National Sample Cohort. MAIN OUTCOME MEASURE: We are interested in new statin users during 2003–2015 in Korea. Information on prescribed statins, including intensity of statins and entry of new and follow-on statins in the market, and healthcare institutions that prescribed the statins were also collected. In time series analysis, we estimated the effect of introduction of generics in the market, specifically for newly prescribed statin users. RESULTS: This 13-year longitudinal study of a sample cohort provided by the National Health Insurance Service found that the incidence of new statin user increase from 838.1/100 000 persons in 2003 to 1626.9/100 000 persons in 2015. Most new users were initiated on a monotherapy that was prescribed at primary healthcare institutions. However, the statin market for new users were quite dynamic in Korea. First, the most commonly prescribed statin changed several times during the study period. Second, the use of moderate-intensity statins increased from 57% in 2003 to 92% in 2015. In line with this result, we could not observe substantial differences in prescription of statins in groups having selected diseases history. Lastly, we found market invasion or switch of statins among new statin users, specifically at primary healthcare institutions. CONCLUSION: Similar to other countries, the incidence of new statin users has been increased in Korea. However, the statin market in Korea is quite dynamic compared with other countries. Interestingly, discounted price of originals after the introduction of generics immediately expand markets or substitute the market particularly in primary healthcare institutions in Korea.
format Online
Article
Text
id pubmed-6430099
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-64300992019-04-05 Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study Son, Kyung-Bok Bae, SeungJin BMJ Open Public Health OBJECTIVE: This study analysed utilisation of statins for new statin users and assessed market dynamics of statins in South Korea. DESIGN: This study is a retrospective cohort study. SETTING: The yearly claims data for statins were retrieved from the National Health Insurance Service-National Sample Cohort. MAIN OUTCOME MEASURE: We are interested in new statin users during 2003–2015 in Korea. Information on prescribed statins, including intensity of statins and entry of new and follow-on statins in the market, and healthcare institutions that prescribed the statins were also collected. In time series analysis, we estimated the effect of introduction of generics in the market, specifically for newly prescribed statin users. RESULTS: This 13-year longitudinal study of a sample cohort provided by the National Health Insurance Service found that the incidence of new statin user increase from 838.1/100 000 persons in 2003 to 1626.9/100 000 persons in 2015. Most new users were initiated on a monotherapy that was prescribed at primary healthcare institutions. However, the statin market for new users were quite dynamic in Korea. First, the most commonly prescribed statin changed several times during the study period. Second, the use of moderate-intensity statins increased from 57% in 2003 to 92% in 2015. In line with this result, we could not observe substantial differences in prescription of statins in groups having selected diseases history. Lastly, we found market invasion or switch of statins among new statin users, specifically at primary healthcare institutions. CONCLUSION: Similar to other countries, the incidence of new statin users has been increased in Korea. However, the statin market in Korea is quite dynamic compared with other countries. Interestingly, discounted price of originals after the introduction of generics immediately expand markets or substitute the market particularly in primary healthcare institutions in Korea. BMJ Publishing Group 2019-03-05 /pmc/articles/PMC6430099/ /pubmed/30842117 http://dx.doi.org/10.1136/bmjopen-2018-026603 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Public Health
Son, Kyung-Bok
Bae, SeungJin
Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study
title Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study
title_full Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study
title_fullStr Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study
title_full_unstemmed Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study
title_short Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study
title_sort patterns of statin utilisation for new users and market dynamics in south korea: a 13-year retrospective cohort study
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430099/
https://www.ncbi.nlm.nih.gov/pubmed/30842117
http://dx.doi.org/10.1136/bmjopen-2018-026603
work_keys_str_mv AT sonkyungbok patternsofstatinutilisationfornewusersandmarketdynamicsinsouthkoreaa13yearretrospectivecohortstudy
AT baeseungjin patternsofstatinutilisationfornewusersandmarketdynamicsinsouthkoreaa13yearretrospectivecohortstudy